Envista's $508M Profit Reflects Non-Cash Gain

Dental product buyers and finance teams should weigh the $65 million adjusted net income over the GAAP headline figure.

Updated on Nov. 5, 2026 in Corporate Finance

Isometric editorial illustration of stacked steel dental-instrument forms, one hollowed to hold a glowing mustard sphere, on a deep teal plane. — Envista Holdings reported $508 million in third-quarter 2026 GAAP net income, but the total was driven by a $428 million non-cash currency gain, leaving adjusted net income at $65 million. AI Illustration. Upload story photo >

Envista Holdings Corporation reported third quarter 2026 results, posting GAAP net income of $508 million, driven largely by a $428 million non-cash foreign currency translation gain tied to legal entity dissolutions. The company also raised its full-year 2026 adjusted diluted EPS guidance to $1.54 to $1.58.

Why it matters

The headline GAAP figure is not a sign of operating strength: the translation gain had no cash impact and came from restructuring legal entities, so operators comparing margins should look at the adjusted line. Adjusted net income was $65 million for the quarter, far below the GAAP figure.

Envista reported Q3 2026 GAAP net income of $508 million against a loss of $(30) million a year earlier, while adjusted net income was $65 million and adjusted diluted EPS was $0.40. The company repurchased 386 thousand shares for roughly $10 million and retained $273 million in remaining repurchase capacity.

The players

Envista Holdings Corporation

Envista is a Brea, California-based dental products company that manufactures and sells dental equipment, implants, and orthodontic products to dental professionals worldwide.

The details

The $428 million gain was a foreign currency translation adjustment recognized in operating profit, equal to about $2.62 per diluted share before tax. It resulted from the dissolution of certain legal entities as part of legal entity simplification efforts, releasing cumulative translation adjustments that had built up on the balance sheet. Because the gain carried no cash impact, operating cash flow of $78 million and free cash flow of $63 million are the more reliable indicators of the quarter's underlying performance.

October 2, 2026: Third quarter 2026 ended.
November 4, 2026: Results announced and investor conference call held at 2:00 p.m. PT.

Market Landscape

Large one-time translation gains from entity dissolutions can inflate GAAP results well above underlying performance, a pattern that makes adjusted measures the standard comparison point for investors. Envista's quarter illustrates how a company restructuring its international legal footprint can produce a headline profit swing unrelated to sales or operations.

Operators and finance teams benchmarking against Envista should use adjusted EBITDA and adjusted EPS rather than GAAP net income when comparing performance. Suppliers and dental practices tracking the company's spending should note the $10 million buyback and the raised guidance as signals of management's confidence in operating trends.

The takeaway

Treat the $428 million translation gain as an accounting event rather than operating income when evaluating Envista's results or any peer's similar restatement. Track whether the raised $1.54 to $1.58 adjusted EPS guidance holds through the fourth quarter, since that figure reflects the business's underlying earnings power.